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A B S T R A C T
The objective of this study was to investigate the effect of pulmonary tuberculosis on the body fat distribution pattern
and the sensitivity of different skinfold sites with disease and treatment among the adult tribals of Manipur, Northeast
India. A total of four anthropometric measurements and skinfold thickness at five different sites were taken for the study.
The indices of adiposity like body mass index, waist hip ratio and grand mean thickness were computed. The cross sec-
tional sample included tuberculosis (TB) patients (n=167) at different stages of treatment and healthy non patients as
controls (n=80). The subjects ranged in age from 20–40 years. Wasting of muscle mass and decrease in fat mass because
of chronic disease (TB) and overall improvement in these components along with redistribution of fat with TB treatment
was observed.
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Introduction
Tuberculosis as one of the chronic diseases is on the
rise throughout the world and is one of the most impor-
tant causes of death among adults in developing coun-
tries. In 1993, the World Health Organization declared
TB to be a »global health emergency«1. Pulmonary TB, a
chronic infectious disease caused by Mycobacterium tu-
berculosis is characterized by prolonged cough, hemo-
ptysis, chest pain and dyspnea. Systemic manifestation
of the disease include fever, malaise, anorexia, weight
loss, weakness and night sweats2.
The wasting of soft tissues as a cardinal sign of TB
even in ancient time led to speculation that the impact of
this disease eventually extends beyond the lungs. The
notion that a certain kind of body build predisposes a
person to tuberculosis dates back to Hippocrates3. The
risk of developing tuberculosis was found to be more
among tall and thin individuals than those who were
short and heavy set4–7. It was also found that malnutri-
tion predisposes a person to tuberculosis8–10. Besides all
these, socio-economic status is also one of the important
factors which contribute to the rise of tuberculosis11–14.
Numerous studies suggested that assessing the distri-
bution of fat is as important as measuring the amount of
fat15–18. Fat distribution pattern is associated with many
cardiovascular risk factors19–22. Research in fat distribu-
tion has shown that fat deposits at different sites vary in
its metabolic function15,23.
Chronic disease is one of the factors which influences
the total body fat content and its distribution pattern
over the body. The body contour fat patterning has
drawn considerable attention recently because of its as-
sociation with several diseases15,24–26. The importance of
the body fatness and its distribution lies in the epidemio-
logical studies and as a clinical marker of health risk
among populations27. However, very less is known about
subcutaneous fat distribution and tuberculosis28. Weight
loss with a concomitant loss of body fat and nutritional
depletion are observed frequently in patients with pul-
monary tuberculosis, but the effect of this chronic dis-
ease on fat distribution at various sites of the body has
not been paid much attention to. Thus, the present study
was conducted to investigate the effect of tuberculosis on
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the body fat distribution pattern among the tribals of
Northeast India.
Materials and Methods
The present study was carried out in Manipur which
lies in the North-Eastern region of the Indian Sub-conti-
nent, between 23°50' latitudes and 25°30' North and
93°10' and 94°30' East longitudes, bordering Myanmar in
the East, Nagaland in the North, Assam and Mizoram in
the West. According to the census 200129, Manipur has a
population of around 2,388,634 out of which the tribal
population accounts for approximately 30% of the total
population.
In the tribal life the principal links for the whole soci-
ety are based on kinship. Lineages, clans and other social
groupings tend to be the main corporate units and »they
are often the principal units for land ownership, for eco-
nomic production and consumption«30. The tribals have
their own traditional customs and customary laws. In
Manipur two sharply distinct adaptive patterns- shifting
cultivation (jhuming) and settled wet cultivation are
practiced. In general, the tribal economic systems are ba-
sically self-sufficient and that these are subsistence econ-
omies but due to modernization and education, the qual-
ity of life has improved to a considerable extent. The
staple food of the tribals of Manipur is rice. They also
consume red meat in large amount.
A total of 247 adult tribal males were included in the
present study, out of which 167 adults were suffering
from tuberculosis, while 80 subjects were disease free
and were apparently healthy adults. The former group
was taken as test group whereas the latter as controls.
All confirmed cases of pulmonary TB who have not
started the TB treatment were termed as BST, all those
who were confirmed as having taken treatment regularly
for two months were grouped as 2MOT and those who
were declared as having taken full treatment as ACT (6
to 8 months of treatment). A group of young healthy
adults confirmed as never having any type of TB were
taken as control group (CG). The grouping was done in
consultation with doctors based on their experience of
TB disease, the patients and its treatment. The guide-
lines for selection were laid down and all volunteers fit-
ting into that guideline frame were accepted as part of
the study. A well informed written consent from the sub-
jects for their willingness to participate in the present
study was taken before the measurements were taken.
Each subject was measured for weight, height, waist
circumference, hip circumference and skinfold thickness
at biceps, triceps, subscapular, suprailiac and calf poste-
rior sites. All the measurements were taken by following
the techniques described by Weiner & Lourie (1981)31.
The various indices for assessing regional and general
adiposity viz.: waist-to-hip ratio (WHR), body mass index
(BMI) calculated as body weight in kg divided by height
in meter square [BMI=wt(kg)/height(m2)] and grand
mean thickness (GMT) was also computed. Waist/hip cir-
cumference ratio (WHR) has been used to differentiate
the distribution of body fat on lower and upper body. The
ratio of waist/hip circumference (WHR) was introduced
as a simple index of body fat distribution and was subse-
quently found to be a more sensitive index of metabolic
abnormalities in the obese than the use of neck, bust,
waist or hip circumference measurements alone33–35. For
lower body fat predominance the ratio is <0.73 indicat-
ing femoral gluteal fat deposits and for upper body fat
the dominance, the ratio is >0.8036.
To study the responsiveness of various skinfold sites
towards accumulation of fat as a consequence of TB
treatment each skinfold thickness was expressed as per-
cent of grand mean thickness (%GMT). The profile of
subcutaneous fat distribution over the body surface was
obtained by arranging the various skinfold sites in as-
cending order of their thickness.
Descriptive statistics were done for height, body
weight, BMI, WHR, skinfold thicknesses and GMT in
subjects at different stages of TB treatment and healthy
controls. The t-test was used for comparison between the
different groups of subjects. The differences between the
test groups and healthy controls in respect of the indica-
tors of fatness were tested by one way analysis of vari-
ance (ANOVA). All data was analyzed using SPSS 13.0
version.
Results
Table 1 presents the means and standard deviations
of body weight, height, waist circumference, hip circum-
ference, body mass index and waist hip ratio among the
subjects in different groups. The mean values of body
weight, height and BMI were found to be lowest among
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TABLE 1
BASIC DATA OF THE SUBJECTS
Subjects BW (kg) Ht (cm) WC (cm) HC (cm) BMI (kg/m2) WHR
BST(n-62) X±SD 46.8±6.64 161.6±5.88 64.6±4.94 78.8±4.70 17.9±2.18 0.82±0.05
2MOT(n-55) X±SD 50.1±6.13 163.5±5.23 68.4±5.6 80.3±5.13 18.7±2.14 0.85±0.05
ACT(n-50) X±SD 51.8±6.09 163.5±4.93 66.4±5.16 79.7±4.8 19.4±2.0 0.83±0.05
CG(n-80) X±SD 57.4±5.82 163.9±5.71 71.0±7.63 84.5±5.93 21.4±2.12 0.84±0.06
CG – healthy controls, BST – before starting treatment, 2MOT – after two months of treatment, ACT – After completion of treatment
BW – body weight, Ht – height, WC – waist circumference, HC – hip circumference, BMI – body mass index, WHR – waist hip ratio
the TB patients who have not started treatment (BST)
and increased gradually with treatment. However, the
mean values of waist circumference, hip circumference
and WHR though found to be least among TB patients
before starting treatment increased significantly till two
months of treatment. The mean values of body weight,
height, waist circumference, hip circumference and body
mass index were found to be highest among the healthy
controls. Whereas, the mean value of waist hip ratio was
found to be the highest among TB patients after two
months of treatment.
The means and standard deviations of skinfold thick-
ness at biceps, triceps, calf posterior, subscapular, supra-
iliac and grand mean thickness are given in Table 2. The
skinfold thickness at all the sites and grand mean thick-
ness showed increase in the mean values from before
starting treatment group till two months of treatment
group and then a decline till completion of treatment.
The mean values of the skinfold thicknesses and grand
mean thickness were found to be highest among the
healthy controls.
Table 3 shows the significance of the difference in var-
ious adiposity indices between the TB patients and healthy
controls. The TB patients at all stages of treatment
showed significantly lower values of grand mean thick-
ness and body mass index as compared to the healthy
controls (p<0.001). The grand mean thickness (p<0.001),
body mass index (p<0.05) and waist hip ratio (p<0.01)
showed significant increase till two months of treatment.
The overall response to treatment was evident in the sig-
nificant increase (p<0.001) in the mean values of grand
mean thickness and body mass index from the time of
starting treatment till completion of treatment.
Table 4 displays the ANOVA test in the grand mean
thickness, body mass index and waist hip ratio between
TB patients and healthy controls. The ANOVA test sho-
wed significant difference for grand mean thickness (F=
55.02; p<0.01) and body mass index (F=35.26; p<0.01)
among TB patients and healthy controls.
The distribution pattern of subcutaneous fat in TB
patients at different stages of treatment and healthy con-
trols are displayed in Figure 1. The distribution of subcu-
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TABLE 2
SKINFOLD THICKNESSES AND GRAND MEAN THICKNESS OF THE SUBJECTS
Subjects BSF (mm) TSF (mm) CPSF (mm) SSSF (mm) SISF (mm) GMT (mm)
BST(n-62) X±SD 3.8±1.08 6.0±1.15 5.6±1.78 7.0±1.55 6.0±1.62 5.7±0.96
2MOT(n-55) X±SD 4.0±0.98 7.7±1.57 7.9±2.90 8.9±2.58 8.2±2.95 7.3±1.80
ACT(n-50) X±SD 4.0±1.09 7.2±1.67 7.6±2.66 8.4±1.89 7.9±2.85 7.0±1.63
CG(n-80) X±SD 5.2±1.49 9.8±2.56 10.8±3.94 11.1±3.62 11.9±4.55 9.8±2.66
CG – healthy controls, BST – before starting treatment, 2MOT – after two months of treatment, ACT – After completion of treatment.
BSF – biceps skinfold thickness, TSF – triceps skinfold thickness, CPSF – calf posterior skinfold thickness, SSSF – subscapular
skinfold thickness, SISF – suprailiac skinfold thickness, GMT – grand mean thickness
TABLE 3
SIGNIFICANCE OF THE DIFFERENCE IN VARIOUS ADIPOSITY
INDICES BETWEEN THE TB PATIENTS AND HEALTHY
CONTROLS
Subject
value of 't' with level of significance
GMT BMI WHR
BST & CG 11.49*** 9.57*** 1.93
2MOT & CG 5.93*** 7.12*** 1.78
ACT & CG 6.59*** 5.4*** 0.50
BST & 2MOT 6.31*** 2.05* 3.27**
2MOT & ACT 0.96 1.56 1.66
BST & ACT 5.34*** 3.64*** 1.32
*p<0.05, **p<0.01, ***p<0.001
CG – healthy controls, BST – before starting treatment, 2MOT –
after two months of treatment, ACT – After completion of treat-
ment.
TABLE 4
ANOVA TEST FOR INDICES OF ADIPOSITY BETWEEN THE




Grand mean thickness 55.02**
Body mass index 35.26**



































Fig. 1. Distribution pattern of subcutaneous fat in TB patients
and healthy controls. CG – healthy controls, BST – before starting
treatment, 2MOT – after two months of treatment, ACT – After
completion of treatment, SF – skinfold.
taneous fat pattern differed in the TB patients and
healthy controls indicating the varied response of differ-
ent skinfold sites leading to fat redistribution with treat-
ment. Although the site of minimum fat stores remained
biceps skinfold thickness the site of maximum fat stores
was subscapular among the TB patients in different
stages of treatment. However, among healthy controls,
suprailiac was the site of maximum subcutaneous fat de-
position. The distribution pattern of subcutaneous fat in
TB patients at different stages of treatment and healthy
non TB patients was as follows:
CG : Biceps < Triceps < Calf posterior <
< Subscapular < Suprailiac
BST: Biceps < Calf posterior < Triceps <
< Suprailiac < Subscapular
2MOT : Biceps < Triceps < Calf posterior <
< Suprailiac < Subscapular
ACT : Biceps < Triceps < Calf posterior <
< Suprailiac< Subscapular
Figure 2 presents the responsiveness of different
skinfold sites for fat loss with TB disease (BST vs CG).
Suprailiac was found to be the most sensitive site fol-
lowed by calf posterior site towards fat depletion. How-
ever, biceps, subscapular and triceps sites were found to
be more resistant towards fat change.
During the regular treatment for TB under DOTS, an
increase in subcutaneous fat was observed which was
most noticeable at suprailiac and calf posterior sites (Fig-
ure 3). Although the suprailiac and calf posterior re-
mained most sensitive sites for subcutaneous fat gain
(Figures 3 and 4), the difference between TB patients
and healthy controls kept on decreasing with duration of
treatment.
Discussion and Conclusion
Body weight is a measure of gross body mass i.e. skel-
eton, muscles and fat and also is a good indicator of nu-
tritional status of an individual or a group of individuals.
In the present study the disease free healthy control
group was found to be heaviest, followed by subjects who
had completed their treatment. Thus, with TB, a deple-
tion of fat and wastage of muscles has been noticed,
which bring about a decrease in body weight as observed
among patients who had not started their treatment.
Similar findings were found in a study among 823,199
Navy recruits4. The study also found morbidity (TB) to
be 3 times greater for underweight than for overweight
men. In the present study it was further found that
proper treatment and improved diet certainly showed an
impact on the body weight37.
In the present study body mass index (BMI) a widely
used method to assess the fatness in human beings was
noticed to be lowest among the subjects who had not
started TB treatment, thereby indicating degeneration
of the body’s soft tissues with chronic disease8,38. The in-
crease in BMI with treatment could only be due to in-
crease in body mass with proper medication as advised by
doctors. The present findings was also supported by the
study done by Tverdal (1986)5, among 1717655 subjects,
where he found that incidence of pulmonary TB de-
creased with increasing body mass index (BMI) for both
sexes and all age groups, which was mainly attributed to
be due to the weight component.
Waist circumference is an index of deep adipose tis-
sue39 and is related to fat free mass40. Waist to hip cir-



























Fig. 2. Responsiveness of different skinfold sites for fat loss with
TB disease (BST vs CG). CG – healthy controls, BST – before


























Fig. 3. Responsiveness of different skinfold sites for fat gain with
TB treatment (2MOT vs CG). CG – healthy controls, 2MOT – after
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Fig. 4. Responsiveness of different skinfold sites for fat gain with
TB treatment (ACT vs CG). CG – healthy controls, ACT – After
completion of treatment, SF – skinfold, GMT – grand mean
thickness.
cumference ratio (WHR) is an indicator of the degree of
masculine distribution of adipose tissue: the higher the
WHR, the more masculine the pattern of adipose tissue
distribution and the greater the risk of diseases such as
noninsulin dependent diabetes mellitus36,41. In the pres-
ent study, the WHR was found to be least among TB pa-
tients (BST) and a significant increase was observed till
two months of treatment (p<0.01). The increase in WHR
with TB treatment has been brought by the more sensi-
tive behaviour of suprailiac site for fat accumulation.
This also suggests that a central deposition of adipose tis-
sue is a response to stress acting through the adrenal
cortex42. According to the WHR values36, the TB patients
and healthy subjects had more androidal pattern of fat
deposition.
Skinfold thickness measured at different body sites
gives an account of relative fatness for comparison pur-
poses and also indicate the distribution pattern of subcu-
taneous fat over the entire body. The purpose of assess-
ing the profile of fatness among subjects who were at
different stages of treatment and the healthy control
group was to visualize the changes if any in the subcuta-
neous fat distribution pattern due to the effect of TB and
its treatment. The skinfold thickness taken at various
sites were significantly higher in disease free healthy
controls as compared to the TB patients at all stages of
treatment. This indicates that the healthy controls had
better energy reservoir, better nutritional status than
the subjects who had TB and who were under TB treat-
ment. An improvement in energy storage is seen over
time with treatment among TB patients as seen in in-
creasing skinfold thickness levels with different stages of
treatment (i.e., BST, 2MOT & ACT).
Among TB patients (BST) all the skinflold thick-
nesses were found to be least and this could be a reflec-
tion for decreased energy stores due to depletion of fat
with chronic disease. The situation changed during the
course of treatment. A continuous increasing body
weight with treatment can be attributed to increase in
muscle mass as well as subcutaneous fat. Fat re-distribu-
tion start manifesting itself from the time treatment
started. There is loss of trunkal as well as extremity fat
from the time a person is infested with the disease.
The increase in BMI, an index of overweight/obesity
and a simultaneous increase in the GMT of skinfold
thickness with TB treatment would entail this increase
in body weight due to increase in fatness. In the present
study healthy controls were found to have higher values
of all the five skinfold thicknesses as compared to the TB
patients (BST, 2MOT & ACT) and subsequent increase
in fatness with TB treatment. All the skinfold thick-
nesses, indices of fatness, profile of subcutaneous fat dis-
tribution and sensitivity of each skinfold site showed an
increasing fat deposition on trunkal region with treatment.
Sensitivity of the five skinfold sites towards fat deple-
tion in BST and accumulation in 2MOT and ACT showed
variation at different sites in different stages of treat-
ment. Suprailiac was found to be the most sensitive site
towards fat loss followed by calf posterior. This phenome-
non of increase in trunkal fat with impaired health con-
dition and nutritional intake, if continued undetected
may become detrimental to health due to metabolic dis-
orders like type II diabetes.
The grand mean thickness (GMT) values were found
to increase with treatment and the highest value was
found in disease free healthy subjects. The increase in
fatness level is mainly due to improved health status of
the present subjects. The greater variability observed in
subcutaneous fatness among disease free controls could
be attributed to variability in nutrition intake, physical
and recreational activity. Such variability would ensure
lots of variation in energy intake and consumption. It is
well established that people show a decrease in their to-
tal body fat content with increasing level of physical ac-
tivity or a decrease in energy intake43. The lesser vari-
ability among patients especially those patients who
were diagnosed cases but had not started treatment may
be due to poor nutritional intake, lack of physical activ-
ity, anorexia, etc. which comes with chronic diseases7,9.
There is no doubt that one of the symptom of tuberculo-
sis is anorexia or loss of appetite which would cause a loss
in body weight with a concomitant decrease in body fat
which was noticeable in the present subjects. The de-
crease in energy intake might be due to less food intake
or improper and or unbalanced diet. It can be influenced
by less food availability, poor eating habits or anorexia.
Thus, with disease a general depletion of fat stores
and muscle wastage was observed and with treatment
the body regained fat, muscle strength and body mass.
Selected anthropometric indices in properly designed
studies can be used as important tools in TB treatment
strategies.
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OBRAZAC DISTRIBUCIJE MASNO]A KAO RIZI^NOG FAKTORA KOD KRONI^NIH OBOLJENJA
ME\U PLEMENIMA SI INDIJE
S A @ E T A K
Cilj ove studije bio je istra`iti utjecaj plu}ne tuberkuloze na distribuciju masno}a te osjetljivost razli~itih ko`nih
nabora na bolest i lije~enje me|u odraslim pripadnicima plemena Manipur u sjeveroisto~noj Indiji. Sveukupno su vr{e-
na ~etiri antropometrijska mjerenja te mjerenja ko`nih nabora na pet razli~itih mjesta. Indikacije pretilosti (indeks
tjelesne mase, odnos struk-kukovi) su tako|er ra~unate i mjerene. Uzorak je uklju~ivao ispitanike koji boluju od tuber-
kuloze (N=167) u razli~itim stadijima lije~enja te zdrave ispitanike kao kontrolnu skupinu (N=80). Starost ispitanika
bila je izme|u 20 i 40 godina. Zamije}en je gubitak mi{i}ne mase i masno}a zbog kroni~nog oboljenja te op}e pobolj{anje
tih komponenata zajedno sa redistribucijom masno}a za vrijeme lije~enja.
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